These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27078158)

  • 1. Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis.
    Wu L; Chaudhary SC; Atigadda VR; Belyaeva OV; Harville SR; Elmets CA; Muccio DD; Athar M; Kedishvili NY
    PLoS One; 2016; 11(4):e0153556. PubMed ID: 27078158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid.
    Belyaeva OV; Klyuyeva AV; Vyas A; Berger WK; Halasz L; Yu J; Atigadda VR; Slay A; Goggans KR; Renfrow MB; Kane MA; Nagy L; Kedishvili NY
    PLoS One; 2024; 19(4):e0301447. PubMed ID: 38557762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation retinoid X receptor agonists increase ATRA signaling in organotypic epithelium cultures and have distinct effects on receptor dynamics.
    Melo N; Belyaeva OV; Berger WK; Halasz L; Yu J; Pilli N; Yang Z; Klyuyeva AV; Elmets CA; Atigadda V; Muccio DD; Kane MA; Nagy L; Kedishvili NY; Renfrow MB
    J Biol Chem; 2023 Jan; 299(1):102746. PubMed ID: 36436565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
    Vedell PT; Lu Y; Grubbs CJ; Yin Y; Jiang H; Bland KI; Muccio DD; Cvetkovic D; You M; Lubet R
    Mol Pharmacol; 2013 Mar; 83(3):698-708. PubMed ID: 23292798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of retinoid-mediated signaling involved in skin homeostasis by RAR and RXR agonists/antagonists in mouse skin.
    Gericke J; Ittensohn J; Mihály J; Alvarez S; Alvarez R; Töröcsik D; de Lera AR; Rühl R
    PLoS One; 2013; 8(4):e62643. PubMed ID: 23638129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
    Williams AP; Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    J Surg Res; 2018 Aug; 228():54-62. PubMed ID: 29907230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid.
    Jiang W; Deng W; Bailey SK; Nail CD; Frost AR; Brouillette WJ; Muccio DD; Grubbs CJ; Ruppert JM; Lobo-Ruppert SM
    Cancer Biol Ther; 2009 Feb; 8(3):289-98. PubMed ID: 19197145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.
    Chou CF; Hsieh YH; Grubbs CJ; Atigadda VR; Mobley JA; Dummer R; Muccio DD; Eto I; Elmets CA; Garvey WT; Chang PL
    J Dermatol Sci; 2018 Jun; 90(3):343-356. PubMed ID: 29599065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid.
    Tang XH; Vivero M; Gudas LJ
    Exp Cell Res; 2008 Jan; 314(1):38-51. PubMed ID: 17727842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
    Garner EF; Stafman LL; Williams AP; Aye JM; Goolsby C; Atigadda VR; Moore BP; Nan L; Stewart JE; Hjelmeland AB; Friedman GK; Beierle EA
    J Neurooncol; 2018 Nov; 140(2):209-224. PubMed ID: 30132166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
    Sakuta T; Kanayama T
    Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells.
    Kim MS; Lim DY; Kim JE; Chen H; Lubet RA; Dong Z; Bode AM
    Mol Carcinog; 2015 Dec; 54(12):1596-604. PubMed ID: 25328014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
    Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.
    Kapetanovic IM; Horn TL; Johnson WD; Cwik MJ; Detrisac CJ; McCormick DL
    Int J Toxicol; 2010; 29(2):157-64. PubMed ID: 20335511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid ameliorates photoaged skin through RAR‑mediated pathway in mice.
    Li Z; Niu X; Xiao S; Ma H
    Mol Med Rep; 2017 Nov; 16(5):6240-6247. PubMed ID: 28849147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of retinoid status on the messenger ribonucleic acid expression of nuclear retinoid receptors alpha, beta, and gamma, and retinoid X receptors alpha, beta, and gamma in the mouse testis.
    Gaemers IC; van Pelt AM; van der Saag PT; Hoogerbrugge JW; Themmen AP; de Rooij DG
    Endocrinology; 1997 Apr; 138(4):1544-51. PubMed ID: 9075714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid x receptor agonists increase bcl2a1 expression and decrease apoptosis of naive T lymphocytes.
    Rasooly R; Schuster GU; Gregg JP; Xiao JH; Chandraratna RA; Stephensen CB
    J Immunol; 2005 Dec; 175(12):7916-29. PubMed ID: 16339527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
    Elmazar MM; Nau H
    Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
    Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    Mol Cancer Ther; 2015 Jul; 14(7):1559-69. PubMed ID: 25944918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced retinoid signaling in the skin after systemic retinoid-X receptor ligand treatment in mice with potential relevance for skin disorders.
    Mihály J; Gericke J; Aydemir G; Weiss K; Carlsen H; Blomhoff R; Garcia J; Rühl R
    Dermatology; 2012; 225(4):304-11. PubMed ID: 23296452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.